GHO debuts with DNA Diagnostics
The Europe-focused healthcare firm’s acquisition of DNA Diagnostics is its first from its debut fund.
Home Private Equity News & Analysis Private Equity Deals & Transactions GHO debuts with DNA Diagnostics
The Europe-focused healthcare firm’s acquisition of DNA Diagnostics is its first from its debut fund.
Copyright PEI Media
Not for publication, email or dissemination